Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med [Internet]. 2012;125(9):882–7. Available from:. https://doi.org/10.1016/j.amjmed.2011.12.013.
Article
Google Scholar
World Health Organization. Cardiovascular disease [Internet]. Available from: http://www.who.int/cardiovascular_diseases/en/.
Ambrose JA, Singh M. Pathophysiology of coronary artery disease leading to acute coronary syndromes. F1000Prime Rep [Internet]. 2015;7:08 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25705391%5Cn, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4311268.
Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004;14(3):271–9.
Article
CAS
PubMed
Google Scholar
Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, et al. Eercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical. Circulation. 2003;107(24):3109–16.
Article
PubMed
Google Scholar
Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458–73.
Article
PubMed
Google Scholar
Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. CMAJ [Internet]. 2006;174(6):801–9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16534088%255Cn, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1402378.
Anderson L, Oldridge N, Thompson DR, Zwisler A-D, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol [Internet]. 2016;67(1):1–12 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0735109715071193.
Article
Google Scholar
Jolliffe J, Rees K, Taylor-Rod RS, Thompson DR, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. JolliffeJudith, ReesKaren, TaylorRodRS, ThompsonDavidR, OldridgeNeil, EbrahimShahExercise based Rehabil Coron Hear Dis Database Syst Rev Rev 2001Issue1 JohnWiley Sons, LtdChichester, UK D. 2001;(1).
Bunevicius A, Staniute M, Brozaitiene J, Pop VJM, Neverauskas J, Bunevicius R. Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life Outcomes [Internet]. 2013;11(1):37 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3601013&tool=pmcentrez&rendertype=abstract.
Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, et al. Recommendations for Screening , Referral , and Treatment A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing , Council on Clinical. Circulation. 2008;118:1768–75.
Article
PubMed
Google Scholar
Ligthart SA, Richard E, Fransen NL, Eurelings LSM, Beem L, Eikelenboom P, et al. Association of Vascular Factors with Apathy in community-dwelling elderly individuals. Arch Gen Psychiatry [Internet]. 2012;69(6):7–9 Available from: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2011.1858.
Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, et al. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. J Clin psychiatry [internet], Available from. 2011, 72(9):1181–8 http://www.ncbi.nlm.nih.gov/pubmed/21208573.
Article
PubMed
Google Scholar
Silbert BS, Scott DA, Evered LA, Lewis MS, Maruff PT. Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery. Anesth Analg. 2007;104(5):1023–8.
Article
PubMed
Google Scholar
van der Mast RC, Vinkers DJ, Stek ML, Bek MC, Westendorp RGJ, Gussekloo J, et al. Vascular disease and apathy in old age. The Leiden 85-plus study. Int J Geriatr Psychiatry. 2008;23(3):266–71.
Article
PubMed
Google Scholar
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: A clinical review. Eur Heart J. 2014;35(21):1365–72.
Article
PubMed
Google Scholar
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in Heart Failure. A Meta-Analytic Review of Prevalence, Intervention Effects, and Associations With Clinical Outcomes. J Am Coll Cardiol. 2006;48:1527–37.
Article
PubMed
Google Scholar
Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med [Internet]. 2004;66(5):645–50 Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006842-200409000-00004.
Article
PubMed
Google Scholar
Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med [Internet]. 2004;66(6):802–13 Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006842-200411000-00003.
Article
Google Scholar
Frasure-Smith N, Lespérance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry. 2003;60(6):627–36.
Article
PubMed
Google Scholar
Khayyam-Nekouei Z, Neshatdoost H, Yousefy A, Sadeghi M, Manshaee G. Psychological factors and coronary heart disease. ARYA Atheroscler [Internet]. 2013;9(1):102–11 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3653260&tool=pmcentrez&rendertype=abstract.
Google Scholar
Tully PJ, Harrison NJ, Cheung P, Cosh S. Anxiety and Cardiovascular Disease Risk: a Review. Curr Cardiol Rep [Internet]. 2016;18(12). Available from: https://doi.org/10.1007/s11886-016-0800-3
Cardiac Care Network. Standards for the Provision of Cardiovascular Rehabilitation in Ontario [Internet]. Available from: https://www.corhealthontario.ca/resources-for-healthcare-planners-&-providers/rehabilitation/CCN_Cardiovascular_Rehab_Standards_2014.pdf.
Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. Circulation [Internet]. 2007;115(20):2675–82 Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.180945.
Article
PubMed
Google Scholar
Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Cohen A, Thorpe KE, et al. The “dOC” screen: feasible and valid screening for depression, obstructive sleep apnea (OSA) and cognitive impairment in stroke prevention clinics. PLoS One. 2017;12(4):1–18.
Article
Google Scholar
Kapoor A, Lanctot KL, Bayley M, Herrmann N, Murray BJ, Swartz RH. Screening for Post-Stroke Depression and Cognitive Impairment at Baseline Predicts Long-Term Patient-Centered Outcomes After Stroke. J Geriatr Psychiatry Neurol. 2019;32(1):40–48.
Article
PubMed
Google Scholar
Khan MM, Lanctot KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, et al. The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clin Interv Aging. 2019;14:841–8.
Article
Google Scholar
Eggermont LHP, de Boer K, Muller M, Jaschke AC, Kamp O, Scherder EJA. cardiac disease and cognitive impairment: a systematic review. Heart. 2012;98(18):1334–40.
Article
PubMed
Google Scholar
Zheng L, MacK WJ, Chui HC, Heflin L, Mungas D, Reed B, et al. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc. 2012;60(3):499–504.
Article
PubMed
PubMed Central
Google Scholar
Gayda M, Gremeaux V, Bherer L, Juneau M, Drigny J, Dupuy O, et al. Cognitive function in patients with stable coronary heart disease: Related cerebrovascular and cardiovascular responses. PLoS One. 2017;12(9):e0183791.
Article
PubMed
PubMed Central
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
Article
Google Scholar
Pendlebury ST, Mariz J, Bull L, Mehta Z. Rothwell PM. ACE-R, and MMSE versus the national institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards neuropsychological battery after TIA and stroke. Stroke: MoCA; 2012.
Google Scholar
Horton DK, Hynan LS, Lacritz LH, Rossetti HC, Weiner MF, Cullum CM. An abbreviated Montreal cognitive assessment (MoCA) for dementia screening. Clin Neuropsychol. 2015;29(4):413–25.
Article
PubMed
PubMed Central
Google Scholar
Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, et al. Defining and validating a short form Montreal cognitive assessment (s-MoCA) for use in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2016;87(12):1303–10.
Article
PubMed
PubMed Central
Google Scholar
Cheng Y-W, Chen T-F, Chiu M-J. From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution. Neuropsychiatr Dis Treat. 2017;13:491–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–53.
Article
PubMed
PubMed Central
Google Scholar
McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the heart and soul study). Am J Cardiol [Internet]. 2005;96(8):1076–81 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2776683&tool=pmcentrez&rendertype=abstract%5Cn, http://www.sciencedirect.com/science/article/pii/S0002914905011665.
Article
Google Scholar
Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: A concise review for clinicians. Postgrad Med. 2015;127:99–106.
Article
PubMed
Google Scholar
Prisnie JC, Fiest KM, Coutts SB, Patten SB, CAM A, Blaikie L, et al. Validating screening tools for depression in stroke and transient ischemic attack patients. Int J Psychiatry Med. 2016;51(3):262–77.
Article
PubMed
Google Scholar
Wild B, Eckl A, Herzog W, Niehoff D, Lechner S, Maatouk I, et al. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry. 2014;22(10):1029–38.
Article
PubMed
Google Scholar
Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013;6(4):498–504.
Article
PubMed
Google Scholar
Robert P, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein S, et al. Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur Psychiatry. 2009;24(2):98–104.
Article
CAS
PubMed
Google Scholar
Eurelings LSM, Ligthart SA, Van Dalen JW, Moll Van Charante EP, Van Gool WA, Richard E. Apathy is an independent risk factor for incident cardiovascular disease in the older individual: A population-based cohort study. Int J Geriatr Psychiatry. 2014;29(5):454–63.
Article
PubMed
Google Scholar
Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke; 2009.
Book
Google Scholar
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–41.
Article
PubMed
Google Scholar
Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL. Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease. Neuropsychiatr Dis Treat. 2016;12:2913–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275–89.
Article
PubMed
PubMed Central
Google Scholar
Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38(2):143–62.
Article
CAS
PubMed
Google Scholar
Clarke DE, Reekum RV, Simard M, Streiner DL, Freedman M, Conn D. Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatr [Internet]. 2007;19(1):57–64. Available from:. https://doi.org/10.1176/appi.neuropsych.19.1.57.
Article
Google Scholar
Cheng W, Lai C. Satisfaction scale for community nursing: development and validation. J Adv Nurs. 2010;66(10):2331–40.
Article
PubMed
Google Scholar
Cullen B, O’Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment, vol. 78. Neurosurgery and Psychiatry: J Neurol; 2007. p. 790–9.
Google Scholar
Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. Can J Emerg Med. 2006;8(1):19–20.
Google Scholar
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315–6.
Article
PubMed
Google Scholar
Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Smith EE, Sahlas DJ, et al. Validating a pragmatic approach to cognitive screening in stroke prevention clinics using the Montreal cognitive assessment. Stroke. 2016;47(3):807–13.
Article
PubMed
Google Scholar
Hermans H, van der Pas FH, Evenhuis HM. Instruments assessing anxiety in adults with intellectual disabilities: A systematic review. Res Dev Disabil. 2011;32:861–70.
Article
PubMed
Google Scholar
Sharp LK, Lipsky MS. Screening for depression across the lifespan: A review of measures for use in primary care settings. Am Fam Physician. 2002;66(6):1001–8.
PubMed
Google Scholar
Klekociuk SZ, Summers JJ, Vickers JC, Summers MJ. Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological assessment. Eur J Neurol. 2014;21(10):1330–e83.
Article
CAS
PubMed
Google Scholar
Maji B, Larner AJ. Screening for dementia: is one simple question the answer? Clin Med J R Coll Physicians London. 2015;15(1):111–2.
Google Scholar
Larner AJ. Speed versus accuracy in cognitive assessment when using CSIs. Prog Neurol Psychiatry. 2015;19(1):21–4.
Article
Google Scholar
Fujii D, Hishinuma E, Masaki K, Petrovich H, Ross GW, White L. Dementia screening: can a second administration reduce the number of false positives? Am J Geriatr Psychiatry. 2003;11(4):462–5.
Article
PubMed
Google Scholar
Gostoli S, Roncuzzi R, Urbinati S, Rafanelli C. Clinical and Subclinical Distress, Quality of Life, and Psychological Well-Being after Cardiac Rehabilitation. Appl Psychol Heal Well-Being. 2017;9(3):349–69.
Article
Google Scholar
Tulloch H, Heenan A, Cupper L, Pelletier R, OʼFarrell P, Pipe A. Depression and anxiety screening and triage protocol for cardiac rehabilitation programs. J Cardiopulm Rehabil Prev. 2018;38(3):159–62.
Binetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A, et al. Behavioral disorders in Alzheimer disease: A transcultural perspective. Arch Neurol. 1998;55(4):539–44.
Article
CAS
PubMed
Google Scholar
Hargrave R, Stoeklin M, Haan M, Reed B. Clinical aspects of dementia in African-American, Hispanic, and white patients. J Natl Med Assoc [Internet]. 2000;92(1):15–21 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2640513&tool=pmcentrez&rendertype=abstract.
CAS
Google Scholar
Lanctôt KL, Agüera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, et al. Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimer’s Dement [Internet]. 2017;13(1):84–100 Available from: http://linkinghub.elsevier.com/retrieve/pii/S1552526016302825.
Article
Google Scholar
Sever S, Golder S, Doherty P. Factors associated with acute depressive symptoms in patients with comorbid depression attending cardiac rehabilitation. BMC Cardiovasc Disord. 2018;18(230):1–8.
Google Scholar
Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt KL. Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease. J Rehabil Med. 2008;40(3):213–8.
Article
PubMed
Google Scholar
Swardfager W, Herrmann N, Marzolini S, Saleem M, Kiss A, Shammi P, et al. Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease. J Am Geriatr Soc. 2010;58(8):1519–25.
Article
PubMed
Google Scholar
Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, et al. Plasma sphingolipids and depressive symptoms in coronary artery disease. Brain Behav. 2017;7(11):e00836.
Article
PubMed
PubMed Central
Google Scholar
Saleem M, Herrmann N, Dinoff A, Mielke MM, Oh PI, Shammi P, et al. A Lipidomics approach to assess the association between plasma sphingolipids and verbal memory performance in coronary artery disease patients undertaking cardiac rehabilitation: A C18:0 signature for cognitive response to exercise. J Alzheimers Dis. 2017;60(3):829–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Milani SA, Marsiske M, Striley CW. Discriminative ability of Montreal cognitive assessment subtests and items in racial and ethnic minority groups. Alzheimer Dis Assoc Disord. 2019:1–7.
Goldstein FC, Ashley AV, Miller E, Alexeeva O, Zanders L, King V. Validity of the Montreal cognitive assessment as a screen for mild cognitive impairment and dementia in African Americans. J Geriatr Psychiatry Neurol. 2014;27(3):199–203.
Article
PubMed
Google Scholar
Galenkamp H, Stronks K, Snijder MB, Derks EM. Measurement invariance testing of the PHQ-9 in a multi-ethnic population in Europe: the HELIUS study. BMC Psychiatry. 2017;17(1):349.
Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, et al. The GPCOG: A new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50(3):530–4.
Article
PubMed
Google Scholar